Clonal expansion of T cells harboring replication-competent virus has recently been demonstrated in patients on suppressive antiretroviral therapy (ART) regimens. However, there has not been direct evidence of this phenomenon in settings of natural control, including in posttreatment controllers who maintain control of viral replication after treatment when ART is discontinued. We present a case of an individual who has had undetectable viral loads for more than 15 years following the cessation of ART. Using near-full-genome sequence analysis, we demonstrate that 9 of 12 replication-competent isolates cultured from this subject were identical and that this identity was maintained 6 months later. A similar pattern of replication-competent virus clonality was seen in a treatment-naive HLA-B*57 elite controller. In both cases, we show that CD8+ T cells are capable of suppressing the replication of the clonally expanded viruses in vitro. Our data suggest that, while clonal expansion of replication-competent virus can present a barrier to viral eradication, these viral isolates remain susceptible to HIV-specific immune responses and can be controlled in patients with long-term suppression of viral replication.
Rebecca T. Veenhuis, Abena K. Kwaa, Caroline C. Garliss, Rachel Latanich, Maria Salgado, Christopher W. Pohlmeyer, Christopher L. Nobles, John Gregg, Eileen P. Scully, Justin R. Bailey, Frederic D. Bushman, Joel N. Blankson
Title and authors | Publication | Year |
---|---|---|
HIV controllers: hope for a functional cure
Deng Z, Yan H, Lambotte O, Moog C, Su B |
Frontiers in Immunology | 2025 |
Comparative analysis of within-host dynamics of acute infection and viral rebound dynamics in postnatally SHIV-infected ART-treated infant rhesus macaques
Mainou E, Berendam SJ, Obregon-Perko V, Uffman EA, Phan CT, Shaw GM, Bar KJ, Kumar MR, Fray EJ, Siliciano JM, Siliciano RF, Silvestri G, Permar SR, Fouda GG, McCarthy J, Chahroudi A, Chan C, Conway JM |
2024 | |
Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones
Filippo Dragoni, Abena Kwaa, Caroline Garliss, Rebecca Veenhuis, Bezawit Woldemeskel, Angelica Camilo-Contreras, Haley Raymond, Arbor Dykema, Eileen Scully, Amanda Rosecrans, Kellie Smith, Frederic Bushman, Francesco Simonetti, Joel Blankson |
Journal of Clinical Investigation | 2023 |
Ongoing HIV-1 evolution and reservoir reseeding in two elite controllers with genetically diverse peripheral proviral quasispecies
de Azevedo SS, Côrtes FH, Villela LM, Hoagland B, Grinsztejn B, Veloso VG, Morgado MG, Bello G |
Memórias do Instituto Oswaldo Cruz | 2023 |
Advancements in Cell-Based Therapies for HIV Cure
Matsui Y, Miura Y |
Cells | 2023 |
Elite and posttreatment controllers, two facets of HIV control.
Mastrangelo A, Banga R, Perreau M |
Current Opinion in HIV and AIDS | 2022 |
How elite controllers and posttreatment controllers inform our search for an HIV-1 cure
Jonathan Li, Joel Blankson |
Journal of Clinical Investigation | 2021 |
HIV-specific T-cell responses reflect substantive in vivo interactions with antigen despite long-term therapy
Eva M. Stevenson, Adam R. Ward, Ronald Truong, Allison S. Thomas, Szu-Han Huang, Thomas R. Dilling, Sandra Terry, John K. Bui, Talia M. Mota, Ali Danesh, Guinevere Q. Lee, Andrea Gramatica, Pragya Khadka, Winiffer D. Conce Alberto, Rajesh T. Gandhi, Deborah K. McMahon, Christina M. Lalama, Ronald J. Bosch, Bernard J. Macatangay, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, R. Brad Jones |
JCI Insight | 2021 |
Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication
Marilia Rita Pinzone, Sam Weissman, Alexander O. Pasternak, Ryan Zurakowski, Stephen Migueles, Una O'Doherty |
JCI Insight | 2021 |
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure
JD Siliciano, RF Siliciano |
The Journal of Infectious Diseases | 2021 |
The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
YH Yeh, K Yang, A Razmi, YC Ho |
Viruses | 2021 |
Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence
AS Huang, V Ramos, TY Oliveira, C Gaebler, M Jankovic, MC Nussenzweig, LB Cohn |
Journal of Experimental Medicine | 2021 |
New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir
SC Patro, A Niyongabo, F Maldarelli, MF Kearney |
Viruses | 2021 |
HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
K Kammers, A Chen, DR Monaco, SE Hudelson, W Grant-McAuley, RD Moore, G Alter, SG Deeks, CS Morrison, LA Eller, JN Blankson, O Laeyendecker, I Ruczinski, SH Eshleman, HB Larman |
Frontiers in immunology | 2021 |
Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?
AO Pasternak, CK Psomas, B Berkhout |
Frontiers in microbiology | 2021 |
Immunological effector mechanisms in HIV-1 elite controllers
CA Hartana, XG Yu |
Current Opinion in HIV and AIDS | 2021 |
CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
RT Veenhuis, CC Garliss, JR Bailey, JN Blankson |
Frontiers in immunology | 2021 |
A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques
P Nzounza, G Martin, N Dereuddre-Bosquet, V Najburg, L Gosse, C Ruffié, C Combredet, C Petitdemange, S Souquère, G Schlecht-Louf, C Moog, G Pierron, RL Grand, T Heidmann, F Tangy |
npj Vaccines | 2021 |
Non-suppressible HIV-1 viremia: a reflection of how the reservoir persists
Janet D. Siliciano, Robert F. Siliciano |
Journal of Clinical Investigation | 2020 |
BCL-2 Antagonism Sensitizes Cytotoxic T Cell-Resistant HIV Reservoirs to Elimination Ex Vivo
Yanqin Ren, Szu-Han Huang, Shabnum Patel, Winiffer D. Conce Alberto, Dean Magat, Dughan J. Ahimovic, Amanda B. Macedo, Ryan Durga, Dora Chan, Elizabeth Zale, Talia M. Mota, Ronald Truong, Thomas Rohwetter, Chase D. McCann, Colin M. Kovacs, Erika Benko, Avery Wimpelberg, Christopher M. Cannon, W. David Hardy, Alberto Bosque, Catherine M. Bollard, R. Brad Jones |
Journal of Clinical Investigation | 2020 |
Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy
Annukka A. R. Antar, Katharine M. Jenike, Sunyoung Jang, Danielle N. Rigau, Daniel B. Reeves, Rebecca Hoh, Melissa R. Krone, Jeanne C. Keruly, Richard D. Moore, Joshua T. Schiffer, Bareng A.S. Nonyane, Frederick M. Hecht, Steven G. Deeks, Janet D. Siliciano, Ya-Chi Ho, Robert F. Siliciano |
Journal of Clinical Investigation | 2020 |
Healthy donor T-Cell responses to common cold coronaviruses and SARS-CoV-2
Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss, Oliver Laeyendecker, Stuart C. Ray, Joel N. Blankson |
Journal of Clinical Investigation | 2020 |
Distinct viral reservoirs in individuals with spontaneous control of HIV-1
C Jiang, X Lian, C Gao, X Sun, KB Einkauf, JM Chevalier, SM Chen, S Hua, B Rhee, K Chang, JE Blackmer, M Osborn, MJ Peluso, R Hoh, M Somsouk, J Milush, LN Bertagnolli, SE Sweet, JA Varriale, PD Burbelo, TW Chun, GM Laird, E Serrao, AN Engelman, M Carrington, RF Siliciano, JM Siliciano, SG Deeks, BD Walker, M Lichterfeld, XG Yu |
Nature | 2020 |
CD8+ T cells in HIV control, cure and prevention
DR Collins, GD Gaiha, BD Walker |
Nature Reviews Immunology | 2020 |
Elite suppressors have low frequencies of intact HIV-1 proviral DNA
AK Kwaa, CC Garliss, KD Ritter, GM Laird, JN Blankson |
AIDS | 2020 |
Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication
ME May, CW Pohlmeyer, AK Kwaa, MC Mankowski, JR Bailey, JN Blankson |
Frontiers in Cellular and Infection Microbiology | 2020 |
Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies
BA Woldemeskel, AK Kwaa, JN Blankson |
EBioMedicine | 2020 |
Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV
SE Beck, JN Blankson |
Molecular Therapy | 2020 |
Learning From the Exceptions: HIV Remission in Post-treatment Controllers
B Etemad, E Esmaeilzadeh, JZ Li |
Frontiers in immunology | 2019 |
Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8 + T Cells
AK Kwaa, CA Talana, JN Blankson, G Silvestri |
Journal of virology | 2018 |